This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Milsom I et al. (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87: 760–766
Stewart WF et al. (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20: 327–336
Chapple CR (2002) Muscarinic receptor subtypes and management of the overactive bladder. Urology 60 (5 Suppl 1): 82–88
Landis JR et al. (2004) Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171: 752–756
Acknowledgements
The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Indevus – Consultant/Advisor
Pfizer – Consultant/Advisor;
Meeting Participant/Lecturer; Scientific Study/Trial
Novartis – Consultant/Advisor
Qmed – Scientific Study/Trial
Allergan – Scientific Study/Trial
Rights and permissions
About this article
Cite this article
Rovner, E. Do continent patients with overactive bladder respond to muscarinic receptor antagonists?. Nat Rev Urol 2, 472–473 (2005). https://doi.org/10.1038/ncpuro0301
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0301